Last 12 months
Inside the activity.
2 purchase rows · 274 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 29 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 37 |
| Apr 2026 | 0 | 22 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 152 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 6 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Chadwick Jeremy GChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,150 | $0.00 Strike: $90.10 | $0.00 |
DisclosureSEC source: 0001193125-26-091985 · ownership.xml · derivative · entry 9 Chadwick Jeremy G · CIK 0001388406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,150 Underlying: Common Stock · 25,150 shares Expires 2036-03-01 F11 · derivative.exercise_date: The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Chadwick Jeremy GChief Operating Officer
|
SaleCommon Stock | 1,107 | $89.66 | $99,250.74 |
DisclosureSEC source: 0001193125-26-091985 · ownership.xml · nonDerivative · entry 4 Chadwick Jeremy G · CIK 0001388406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,729 F3 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.17 to $90.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Chadwick Jeremy GChief Operating Officer
|
SaleCommon Stock | 383 | $88.50 | $33,895.65 |
DisclosureSEC source: 0001193125-26-091985 · ownership.xml · nonDerivative · entry 3 Chadwick Jeremy G · CIK 0001388406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,836 F3 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.11 to $89.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Chadwick Jeremy GChief Operating Officer
|
SaleCommon Stock | 549 | $87.75 | $48,175.24 |
DisclosureSEC source: 0001193125-26-091985 · ownership.xml · nonDerivative · entry 2 Chadwick Jeremy G · CIK 0001388406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,219 F3 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.11 to $88.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Chadwick Jeremy GChief Operating Officer
|
GrantCommon Stock | 12,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-091985 · ownership.xml · nonDerivative · entry 1 Chadwick Jeremy G · CIK 0001388406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,768 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in three equal annual installments following March 3, 2025, subject to the reporting person's continued employment through each vesting date. F2 · balance_after: This number includes 773 shares and shares acquired under the Registrant's employee stock purchase plan. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Goodman NoahChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,450 | $0.00 Strike: $90.10 | $0.00 |
DisclosureSEC source: 0001193125-26-091984 · ownership.xml · derivative · entry 2 Goodman Noah · CIK 0002060075 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,450 Underlying: Common Stock · 18,450 shares Expires 2036-03-01 F2 · derivative.exercise_date: The shares underlying this stock option shall vest in fourty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Goodman NoahChief Business Officer
|
GrantCommon Stock | 9,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-091984 · ownership.xml · nonDerivative · entry 1 Goodman Noah · CIK 0002060075 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,306.438 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Gollob JaredChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,300 | $0.00 Strike: $90.10 | $0.00 |
DisclosureSEC source: 0001193125-26-091983 · ownership.xml · derivative · entry 9 Gollob Jared · CIK 0001821198 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,300 Underlying: Common Stock · 35,300 shares Expires 2036-03-01 F10 · derivative.exercise_date: The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Gollob JaredChief Medical Officer
|
SaleCommon Stock | 3,048 | $89.66 | $273,275.76 |
DisclosureSEC source: 0001193125-26-091983 · ownership.xml · nonDerivative · entry 4 Gollob Jared · CIK 0001821198 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,029 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.17 to $90.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Gollob JaredChief Medical Officer
|
SaleCommon Stock | 1,055 | $88.50 | $93,367.92 |
DisclosureSEC source: 0001193125-26-091983 · ownership.xml · nonDerivative · entry 3 Gollob Jared · CIK 0001821198 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,077 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.11 to $89.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Gollob JaredChief Medical Officer
|
SaleCommon Stock | 1,510 | $87.75 | $132,503.86 |
DisclosureSEC source: 0001193125-26-091983 · ownership.xml · nonDerivative · entry 2 Gollob Jared · CIK 0001821198 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,132 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.11 to $88.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Gollob JaredChief Medical Officer
|
GrantCommon Stock | 17,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-091983 · ownership.xml · nonDerivative · entry 1 Gollob Jared · CIK 0001821198 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,642 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Jacobs Bruce N.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,300 | $0.00 Strike: $90.10 | $0.00 |
DisclosureSEC source: 0001193125-26-091982 · ownership.xml · derivative · entry 9 Jacobs Bruce N. · CIK 0001821074 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,300 Underlying: Common Stock · 35,300 shares Expires 2036-03-01 F10 · derivative.exercise_date: The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Jacobs Bruce N.Chief Financial Officer
|
SaleCommon Stock | 4,113 | $89.66 | $368,760.89 |
DisclosureSEC source: 0001193125-26-091982 · ownership.xml · nonDerivative · entry 4 Jacobs Bruce N. · CIK 0001821074 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,483 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.17 to $90.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Jacobs Bruce N.Chief Financial Officer
|
SaleCommon Stock | 1,424 | $88.50 | $126,024.57 |
DisclosureSEC source: 0001193125-26-091982 · ownership.xml · nonDerivative · entry 3 Jacobs Bruce N. · CIK 0001821074 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,596 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.11 to $89.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Jacobs Bruce N.Chief Financial Officer
|
SaleCommon Stock | 2,039 | $87.75 | $178,924.09 |
DisclosureSEC source: 0001193125-26-091982 · ownership.xml · nonDerivative · entry 2 Jacobs Bruce N. · CIK 0001821074 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,020 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Such sales were automatic and not in the discretion of the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.11 to $88.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:00 UTC |
Jacobs Bruce N.Chief Financial Officer
|
GrantCommon Stock | 17,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-091982 · ownership.xml · nonDerivative · entry 1 Jacobs Bruce N. · CIK 0001821074 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,059 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:30 UTC |
Booth BruceDirector
|
SaleCommon Stock | 10,052 | $90.13 | $905,986.76 |
DisclosureSEC source: 0001451612-26-000002 · form4-03042026_040326.xml · nonDerivative · entry 2 Booth Bruce · CIK 0001451612 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 675,341 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.05 to $90.441 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the range set forth in this footnote. F4 · ownership.nature: The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF"). Atlas Venture Associates Opportunity I, L.P. ("AVAO LP") is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:30 UTC |
Booth BruceDirector
|
SaleCommon Stock | 71,814 | $90.13 | $6,472,595.82 |
DisclosureSEC source: 0001451612-26-000002 · form4-03042026_040326.xml · nonDerivative · entry 1 Booth Bruce · CIK 0001451612 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 3,902,667 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.05 to $90.441 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extend of his pecuniary interest therein, if any. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:24 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.08 | $0.00 |
DisclosureSEC source: 0001193125-26-072155 · ownership.xml · derivative · entry 7 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 245,559 Underlying: Common Stock · 30,000 shares Expires 2029-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F6 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:24 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
SaleCommon Stock | 8 | $93.49 | $747.92 |
DisclosureSEC source: 0001193125-26-072155 · ownership.xml · nonDerivative · entry 6 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 666,195 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:24 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
SaleCommon Stock | 1,501 | $92.81 | $139,307.81 |
DisclosureSEC source: 0001193125-26-072155 · ownership.xml · nonDerivative · entry 5 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 666,203 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.20 to $93.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:24 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
SaleCommon Stock | 3,293 | $91.76 | $302,165.68 |
DisclosureSEC source: 0001193125-26-072155 · ownership.xml · nonDerivative · entry 4 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 667,704 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.295 to $92.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:24 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
SaleCommon Stock | 5,434 | $90.39 | $491,179.26 |
DisclosureSEC source: 0001193125-26-072155 · ownership.xml · nonDerivative · entry 3 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 670,997 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.16 to $90.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:24 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
SaleCommon Stock | 19,764 | $89.78 | $1,774,411.92 |
DisclosureSEC source: 0001193125-26-072155 · ownership.xml · nonDerivative · entry 2 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 676,431 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.16 to $90.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 22:24 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 30,000 | $2.08 | $62,400.00 |
DisclosureSEC source: 0001193125-26-072155 · ownership.xml · nonDerivative · entry 1 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 696,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:30 UTC |
Esposito PamelaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $49.10 | $0.00 |
DisclosureSEC source: 0001193125-26-061686 · ownership.xml · derivative · entry 4 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2031-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F4 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:30 UTC |
Esposito PamelaDirector
|
SaleCommon Stock | 600 | $88.10 | $52,860.00 |
DisclosureSEC source: 0001193125-26-061686 · ownership.xml · nonDerivative · entry 3 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.58 to $88.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:30 UTC |
Esposito PamelaDirector
|
SaleCommon Stock | 1,900 | $87.06 | $165,410.01 |
DisclosureSEC source: 0001193125-26-061686 · ownership.xml · nonDerivative · entry 2 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 600 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.52 to $87.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 22:30 UTC |
Esposito PamelaDirector
|
Exercise / conversionCommon Stock | 2,500 | $49.10 | $122,750.00 |
DisclosureSEC source: 0001193125-26-061686 · ownership.xml · nonDerivative · entry 1 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:30 UTC |
Esposito PamelaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $49.10 | $0.00 |
DisclosureSEC source: 0001193125-26-016934 · ownership.xml · derivative · entry 7 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2031-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F4 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:30 UTC |
Esposito PamelaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $31.20 | $0.00 |
DisclosureSEC source: 0001193125-26-016934 · ownership.xml · derivative · entry 6 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 3,000 shares Expires 2034-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F4 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:30 UTC |
Esposito PamelaDirector
|
SaleCommon Stock | 200 | $68.52 | $13,704.00 |
DisclosureSEC source: 0001193125-26-016934 · ownership.xml · nonDerivative · entry 5 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:30 UTC |
Esposito PamelaDirector
|
SaleCommon Stock | 4,900 | $67.99 | $333,145.12 |
DisclosureSEC source: 0001193125-26-016934 · ownership.xml · nonDerivative · entry 4 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.47 to $68.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:30 UTC |
Esposito PamelaDirector
|
SaleCommon Stock | 400 | $66.68 | $26,672.00 |
DisclosureSEC source: 0001193125-26-016934 · ownership.xml · nonDerivative · entry 3 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,100 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.40 to $66.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:30 UTC |
Esposito PamelaDirector
|
Exercise / conversionCommon Stock | 2,500 | $49.10 | $122,750.00 |
DisclosureSEC source: 0001193125-26-016934 · ownership.xml · nonDerivative · entry 2 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 23:30 UTC |
Esposito PamelaDirector
|
Exercise / conversionCommon Stock | 3,000 | $31.20 | $93,600.00 |
DisclosureSEC source: 0001193125-26-016934 · ownership.xml · nonDerivative · entry 1 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:40 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,118 | $0.00 Strike: $32.07 | $0.00 |
DisclosureSEC source: 0001193125-26-004641 · ownership.xml · derivative · entry 2 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,882 Underlying: Common Stock · 3,118 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2023, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:40 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,118 | $32.07 | $99,994.26 |
DisclosureSEC source: 0001193125-26-004641 · ownership.xml · nonDerivative · entry 1 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 666,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2025 Filed Dec 31, 2025 22:23 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.08 | $0.00 |
DisclosureSEC source: 0001193125-25-338415 · ownership.xml · derivative · entry 4 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,559 Underlying: Common Stock · 30,000 shares Expires 2029-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F4 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| December 31, 2025 Filed Dec 31, 2025 22:23 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
SaleCommon Stock | 6,014 | $78.52 | $472,211.46 |
DisclosureSEC source: 0001193125-25-338415 · ownership.xml · nonDerivative · entry 3 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 663,077 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.44 to $78.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 31, 2025 Filed Dec 31, 2025 22:23 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
SaleCommon Stock | 23,986 | $77.95 | $1,869,727.89 |
DisclosureSEC source: 0001193125-25-338415 · ownership.xml · nonDerivative · entry 2 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 669,091 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.44 to $78.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 31, 2025 Filed Dec 31, 2025 22:23 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 30,000 | $2.08 | $62,400.00 |
DisclosureSEC source: 0001193125-25-338415 · ownership.xml · nonDerivative · entry 1 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 693,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:07 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,595 | $0.00 Strike: $38.53 | $0.00 |
DisclosureSEC source: 0001193125-25-323092 · ownership.xml · derivative · entry 2 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,505 Underlying: Common Stock · 2,595 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:07 UTC |
Mainolfi NelloDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,595 | $38.53 | $99,985.35 |
DisclosureSEC source: 0001193125-25-323092 · ownership.xml · nonDerivative · entry 1 Mainolfi Nello · CIK 0001821189 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 663,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:07 UTC |
Esposito PamelaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $31.20 | $0.00 |
DisclosureSEC source: 0001193125-25-323090 · ownership.xml · derivative · entry 10 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 3,000 shares Expires 2034-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F6 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:07 UTC |
Esposito PamelaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $27.67 | $0.00 |
DisclosureSEC source: 0001193125-25-323090 · ownership.xml · derivative · entry 9 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2033-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F6 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:07 UTC |
Esposito PamelaDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,563 | $0.00 Strike: $49.10 | $0.00 |
DisclosureSEC source: 0001193125-25-323090 · ownership.xml · derivative · entry 8 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 12,563 shares Expires 2031-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F6 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:07 UTC |
Esposito PamelaDirector
|
SaleCommon Stock | 1,000 | $84.07 | $84,070.00 |
DisclosureSEC source: 0001193125-25-323090 · ownership.xml · nonDerivative · entry 7 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.99 to $84.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:07 UTC |
Esposito PamelaDirector
|
SaleCommon Stock | 4,099 | $83.45 | $342,064.42 |
DisclosureSEC source: 0001193125-25-323090 · ownership.xml · nonDerivative · entry 6 Esposito Pamela · CIK 0001744425 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,000 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.99 to $83.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.